← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2020Last known activity
Dec 30, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (12 distinct, 8 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (5 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Recent trials (8)
- NCT06752616CollaboratorPhase 2/Phase 3Dec 30, 2024
- NCT06600412CollaboratorPhase 2Sep 18, 2024
- NCT05830162CollaboratorPhase 4Mar 21, 2023
- NCT05415865CollaboratorPhase 3Sep 12, 2022
- NCT05503147CollaboratorPhase 1Mar 24, 2022
- NCT04741945CollaboratorPhase 2Aug 31, 2021
- NCT04893993CollaboratorPhase 4May 12, 2021
- NCT04589351CollaboratorPhase 3Oct 1, 2020
Details
- Last known activity
- Dec 30, 2024